Correlation Between Edgewise Therapeutics and Neurobo Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Neurobo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Neurobo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Neurobo Pharmaceuticals, you can compare the effects of market volatilities on Edgewise Therapeutics and Neurobo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Neurobo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Neurobo Pharmaceuticals.
Diversification Opportunities for Edgewise Therapeutics and Neurobo Pharmaceuticals
-0.82 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Edgewise and Neurobo is -0.82. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Neurobo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurobo Pharmaceuticals and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Neurobo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurobo Pharmaceuticals has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Neurobo Pharmaceuticals go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and Neurobo Pharmaceuticals
Given the investment horizon of 90 days Edgewise Therapeutics is expected to generate 0.57 times more return on investment than Neurobo Pharmaceuticals. However, Edgewise Therapeutics is 1.74 times less risky than Neurobo Pharmaceuticals. It trades about -0.11 of its potential returns per unit of risk. Neurobo Pharmaceuticals is currently generating about -0.16 per unit of risk. If you would invest 3,404 in Edgewise Therapeutics on August 27, 2024 and sell it today you would lose (206.00) from holding Edgewise Therapeutics or give up 6.05% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Edgewise Therapeutics vs. Neurobo Pharmaceuticals
Performance |
| Timeline |
| Edgewise Therapeutics |
| Neurobo Pharmaceuticals |
Edgewise Therapeutics and Neurobo Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Edgewise Therapeutics and Neurobo Pharmaceuticals
The main advantage of trading using opposite Edgewise Therapeutics and Neurobo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Neurobo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurobo Pharmaceuticals will offset losses from the drop in Neurobo Pharmaceuticals' long position.| Edgewise Therapeutics vs. Century Therapeutics | Edgewise Therapeutics vs. C4 Therapeutics | Edgewise Therapeutics vs. Mineralys Therapeutics, Common | Edgewise Therapeutics vs. Cullinan Oncology LLC |
| Neurobo Pharmaceuticals vs. Allarity Therapeutics | Neurobo Pharmaceuticals vs. Virax Biolabs Group | Neurobo Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | Neurobo Pharmaceuticals vs. Biodexa Pharmaceticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |